These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 17139187

  • 1. Vasopeptidase inhibition normalizes blood pressure and restores endothelial function in renovascular hypertension.
    Quaschning T, Hocher B, Ruhl S, Kraemer-Guth A, Tilgner J, Wanner C, Galle J.
    Kidney Blood Press Res; 2006; 29(6):351-9. PubMed ID: 17139187
    [Abstract] [Full Text] [Related]

  • 2. Vasopeptidase inhibition prevents target organ damage and improves survival in spontaneously hypertensive rats.
    Linz W, Schäfer S, Afkham F, Gerl M, Schmidts HL, Rütten H.
    J Renin Angiotensin Aldosterone Syst; 2006 Sep; 7(3):155-61. PubMed ID: 17094052
    [Abstract] [Full Text] [Related]

  • 3. Effect of chronic treatment with the vasopeptidase inhibitor AVE 7688 and ramipril on endothelial function in atherogenic diet rabbits.
    Weckler N, Leitzbach D, Kalinowski L, Malinski T, Busch AE, Linz W.
    J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):191-6. PubMed ID: 14608526
    [Abstract] [Full Text] [Related]

  • 4. Vasopeptidase inhibitor restores the balance of vasoactive hormones in progressive nephropathy.
    Benigni A, Zoja C, Zatelli C, Corna D, Longaretti L, Rottoli D, Maggioni P, Todeschini M, Noris M, Remuzzi G.
    Kidney Int; 2004 Nov; 66(5):1959-65. PubMed ID: 15496167
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics and pharmacodynamics of the vasopeptidase inhibitor AVE7688 in humans.
    Azizi M, Bissery A, Peyrard S, Guyene TT, Ozoux ML, Floch A, Ménard J.
    Clin Pharmacol Ther; 2006 Jan; 79(1):49-61. PubMed ID: 16413241
    [Abstract] [Full Text] [Related]

  • 6. Vasopeptidase inhibition attenuates the progression of renal injury in subtotal nephrectomized rats.
    Cao Z, Burrell LM, Tikkanen I, Bonnet F, Cooper ME, Gilbert RE.
    Kidney Int; 2001 Aug; 60(2):715-21. PubMed ID: 11473654
    [Abstract] [Full Text] [Related]

  • 7. Vasopeptidase inhibition improves insulin sensitivity and endothelial function in the JCR:LA-cp rat.
    Russell JC, Kelly SE, Schäfer S.
    J Cardiovasc Pharmacol; 2004 Aug; 44(2):258-65. PubMed ID: 15243308
    [Abstract] [Full Text] [Related]

  • 8. Angiotensin I-converting enzyme-dependent and neutral endopeptidase-dependent generation and degradation of angiotensin II contrarily modulate noradrenaline release: implications for vasopeptidase-inhibitor therapy?
    Raasch W, Dominiak P, Dendorfer A.
    J Hypertens; 2005 Aug; 23(8):1597-604. PubMed ID: 16003188
    [Abstract] [Full Text] [Related]

  • 9. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.
    Pham I, Gonzalez W, el Amrani AI, Fournié-Zaluski MC, Philippe M, Laboulandine I, Roques BP, Michel JB.
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1339-47. PubMed ID: 8389863
    [Abstract] [Full Text] [Related]

  • 10. The renal antifibrotic effects of angiotensin-converting enzyme inhibition involve bradykinin B2 receptor activation in angiotensin II-dependent hypertension.
    Seccia TM, Belloni AS, Guidolin D, Sticchi D, Nussdorfer GG, Pessina AC, Rossi GP.
    J Hypertens; 2006 Jul; 24(7):1419-27. PubMed ID: 16794493
    [Abstract] [Full Text] [Related]

  • 11. Influence of dietary salts on the cardiovascular effects of low-dose combination of ramipril and felodipine in spontaneously hypertensive rats.
    Mervaala EM, Malmberg L, Teräväinen TL, Laakso J, Vapaatalo H, Karppanen H.
    Br J Pharmacol; 1998 Jan; 123(2):195-204. PubMed ID: 9489606
    [Abstract] [Full Text] [Related]

  • 12. Chronic vasopeptidase inhibition restores endothelin-converting enzyme activity and normalizes endothelin levels in salt-induced hypertension.
    Quaschning T, d'Uscio LV, Shaw S, Viswambharan H, Ruschitzka FT, Lüscher TF.
    Nephrol Dial Transplant; 2001 Jun; 16(6):1176-82. PubMed ID: 11390717
    [Abstract] [Full Text] [Related]

  • 13. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
    Linz W, Wiemer G, Gohlke P, Unger T, Schölkens BA.
    Pharmacol Rev; 1995 Mar; 47(1):25-49. PubMed ID: 7784479
    [Abstract] [Full Text] [Related]

  • 14. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V, Rigamonti A, Fioretti S, Bonomo S, Manfredi B, Ferrario P, Bianchi M, Berti F, Muller EE, Rossoni G.
    Eur J Pharmacol; 2005 Jun 15; 516(3):253-9. PubMed ID: 15963975
    [Abstract] [Full Text] [Related]

  • 15. [Renal tissue angiotensins during converting enzyme inhibition of angiotensin I in spontaneously hypertensive rat].
    Ingert C, Grima M, Michel B, Barthelmebs M, Imbs JL.
    Arch Mal Coeur Vaiss; 1997 Aug 15; 90(8):1135-41. PubMed ID: 9404423
    [Abstract] [Full Text] [Related]

  • 16. Cardiovascular effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme BMS-182657 in experimental hypertension and heart failure.
    Trippodo NC, Robl JA, Asaad MM, Bird JE, Panchal BC, Schaeffer TR, Fox M, Giancarli MR, Cheung HS.
    J Pharmacol Exp Ther; 1995 Nov 15; 275(2):745-52. PubMed ID: 7473162
    [Abstract] [Full Text] [Related]

  • 17. Vasopeptidase inhibition exhibits endothelial protection in salt-induced hypertension.
    Quaschning T, d'Uscio LV, Shaw S, Lüscher TF.
    Hypertension; 2001 Apr 15; 37(4):1108-13. PubMed ID: 11304511
    [Abstract] [Full Text] [Related]

  • 18. Effect of sulfhydryl and non-sulfhydryl angiotensin-converting enzyme inhibitors on endothelial function in essential hypertensive patients.
    Pasini AF, Garbin U, Nava MC, Stranieri C, Pellegrini M, Boccioletti V, Luchetta ML, Fabrizzi P, Lo Cascio V, Cominacini L.
    Am J Hypertens; 2007 Apr 15; 20(4):443-50. PubMed ID: 17386354
    [Abstract] [Full Text] [Related]

  • 19. Vasopeptidase inhibition: a new concept in blood pressure management.
    Burnett JC.
    J Hypertens Suppl; 1999 Feb 15; 17(1):S37-43. PubMed ID: 10340842
    [Abstract] [Full Text] [Related]

  • 20. ACE inhibition promotes upregulation of endothelial progenitor cells and neoangiogenesis in cardiac pressure overload.
    Müller P, Kazakov A, Jagoda P, Semenov A, Böhm M, Laufs U.
    Cardiovasc Res; 2009 Jul 01; 83(1):106-14. PubMed ID: 19380417
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.